Exane BNP Paribas upgraded MACOM Tech from Neutral to Outperform and set a new price target of $135.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/11/2025 | $125.00 | Buy | Truist |
| 4/9/2025 | $135.00 | Neutral → Outperform | Exane BNP Paribas |
| 4/16/2024 | $120.00 | Outperform | Evercore ISI |
| 1/4/2024 | $85.00 | Overweight → Neutral | Piper Sandler |
| 12/15/2023 | $90.00 → $105.00 | Neutral → Buy | BofA Securities |
| 9/6/2023 | $85.00 → $110.00 | Hold → Buy | Craig Hallum |
| 8/28/2023 | $92.00 | Hold → Buy | The Benchmark Company |
| 7/18/2023 | $72.00 | Buy → Neutral | BofA Securities |